Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
312
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Generate Biomedicines Inc market cap is $1.23B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Generate Biomedicines Inc 52 week high is $22.67 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Generate Biomedicines Inc 52 week low is $9.40 as of November 21, 2026.
Generate Biomedicines Inc stock price today is $9.54.
Generate Biomedicines Inc stock price yesterday was $10.37.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Generate Biomedicines Inc P/B ratio is 3.2293.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Generate Biomedicines Inc 50-day moving average is $13.79.